ContractBulk Material Supply Agreement • February 24th, 2011 • Viropharma Inc • Pharmaceutical preparations
*** INDICATES MATERIAL THAT HAS BEEN OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED. ALL SUCH OMITTED MATERIAL HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24b-2 UNDER THE SECURITIES AND EXCHANGE ACT OF 1934, AS AMENDED.
ContractBulk Material Supply Agreement • February 24th, 2011 • Viropharma Inc • Pharmaceutical preparations • New York
*** INDICATES MATERIAL THAT HAS BEEN OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED. ALL SUCH OMITTED MATERIAL HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24b-2 UNDER THE SECURITIES AND EXCHANGE ACT OF 1934, AS AMENDED.
Bulk Material Supply Agreement PARTIES ViroPharma Incorporated, a Delaware corporation, with offices at 397 Eagleview Boulevard, Exton, PA 19341 (“ViroPharma”); and Alpharma Inc., a Delaware corporation with offices at One Executive Drive, Fort Lee,...Bulk Material Supply Agreement • August 2nd, 2006 • Viropharma Inc • Pharmaceutical preparations • New York
sixty (60) days prior to implementation of any such change so that ViroPharma will have reasonable time to allow ViroPharma to update applicable regulatory filings and evaluate the effect on its finished product prior to receiving Product which incorporates the change. However, Alpharma will not notify ViroPharma of any Annual Reportable Changes before implementation. In the event that ViroPharma does not agree to accept Products with changes proposed by Alpharma pursuant to this subsection (b), ViroPharma shall promptly notify Alpharma in writing of that decision. The parties shall then attempt in good faith to resolve ViroPharma’s objections over a thirty (30) day period, failing which resolution ViroPharma shall have the right to terminate this Agreement on [***] months written notice.
Amended and Restated Bulk Material Supply Agreement PartiesBulk Material Supply Agreement • February 28th, 2008 • Viropharma Inc • Pharmaceutical preparations • New York
Expiration Date (Subject to termination provisions): The term of this Agreement shall continue until December 31, 2011 (the “Initial Term”). Following the Initial Term, this Agreement shall automatically renew for a one year period unless ViroPharma delivers written notice to Alpharma of its intention not to renew at least [***] prior to the end of the Initial Term and, thereafter, this Agreement shall renew for consecutive periods of one year (each a “Renewal Term”) unless and until either party submits to the other party written notice of its intention not to renew at least [***] prior to the end of any Renewal Term.
